Smith David V
Insider CIK 1229447 · FPRX Executive Vice President & CFO · CDXS Director · IOBT Director · OGXI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDXS CODEXIS, INC. | A Award deriv | 2026-06-17 | 2026-06-18 | 66,350 | — | $0 | 66,350 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2025-06-10 | 2025-06-12 | 40,983 | — | $0 | 105,705 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 35,144 | — | $0 | 35,144 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2024-06-11 | 2024-06-13 | 30,120 | — | $0 | 64,722 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 45,642 | — | $0 | 45,642 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2023-06-13 | 2023-06-15 | 34,602 | — | $0 | 34,602 | SEC↗ |
| CDXS CODEXIS, INC. | G Gift | 2023-06-13 | 2023-06-15 | 11,273 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2023-06-08 | 2023-06-13 | 41,533 | — | $0 | 41,533 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2022-06-14 | 2022-06-16 | 11,273 | — | $0 | 11,273 | SEC↗ |
| CDXS CODEXIS, INC. | G Gift | 2022-06-14 | 2022-06-16 | 4,796 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 23,885 | — | $0 | 23,885 | SEC↗ |
| IOBT IO Biotech, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 28,019 | — | $0 | 28,019 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2021-06-15 | 2021-06-17 | 4,796 | — | $0 | 4,796 | SEC↗ |
| CDXS CODEXIS, INC. | G Gift | 2021-06-15 | 2021-06-17 | 8,952 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 90,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 90,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 185,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 138,947 | $38.00 | $5.28M | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2021-04-16 | 2021-04-19 | 66,000 | — | $0 | 138,947 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2021-02-24 | 2021-02-26 | 5,110 | $25.71 | $131.4K | 72,947 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-12-11 | 2020-12-15 | 22,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-12-11 | 2020-12-15 | 22,000 | — | $0 | 89,561 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-12-11 | 2020-12-15 | 11,504 | $16.14 | $185.7K | 78,057 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-11-26 | 2020-11-30 | 6,920 | $18.45 | $127.7K | 67,561 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise deriv | 2020-11-11 | 2020-11-13 | 22,000 | — | $0 | 22,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2020-11-11 | 2020-11-13 | 10,908 | $18.00 | $196.3K | 74,481 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | M Exercise | 2020-11-11 | 2020-11-13 | 22,000 | — | $0 | 85,389 | SEC↗ |
| CDXS CODEXIS, INC. | A Award | 2020-06-16 | 2020-06-18 | 8,952 | — | $0 | 8,952 | SEC↗ |
| CDXS CODEXIS, INC. | G Gift | 2020-06-11 | 2020-06-18 | 4,947 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-02-24 | 2020-03-11 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-02-24 | 2020-03-11 | 90,000 | — | $0 | 90,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2020-02-24 | 2020-03-11 | 15,000 | — | $0 | 48,389 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2020-02-24 | 2020-03-11 | 15,000 | — | $0 | 63,389 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2019-11-26 | 2019-11-27 | 6,611 | $3.77 | $24.9K | 33,389 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2019-06-24 | 2019-06-26 | 44,000 | — | $0 | 44,000 | SEC↗ |
| CDXS CODEXIS INC | A Award | 2019-06-11 | 2019-06-13 | 4,947 | — | $0 | 4,947 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-11-26 | 2018-11-27 | 185,000 | — | $0 | 185,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award | 2018-11-26 | 2018-11-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CDXS CODEXIS INC | A Award | 2018-06-11 | 2018-06-12 | 5,923 | — | $0 | 5,923 | SEC↗ |
| CDXS CODEXIS INC | S Sale | 2018-04-03 | 2018-04-05 | 6,000 | $10.37 | $62.2K | 56,679 | SEC↗ |
| CDXS CODEXIS INC | A Award | 2017-06-14 | 2017-06-16 | 17,894 | — | $0 | 62,679 | SEC↗ |
| CDXS CODEXIS INC | A Award | 2016-06-15 | 2016-06-17 | 20,094 | — | $0 | 44,785 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-05-26 | 2016-05-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-05-20 | 2016-05-24 | 2,500 | — | $0 | 9,500 | SEC↗ |
| CDXS CODEXIS INC | A Award | 2016-03-01 | 2016-03-03 | 24,691 | — | $0 | 24,691 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-21 | 2015-05-22 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-20 | 2015-05-22 | 2,500 | — | $0 | 7,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-06-05 | 2014-06-09 | 2,500 | — | $0 | 4,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-05-24 | 2013-05-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-05-23 | 2013-05-28 | 0 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-05-23 | 2013-05-28 | 2,000 | $10.64 | $21.3K | 2,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-31 | 2012-06-04 | 4,000 | — | $0 | 4,000 | SEC↗ |